key: cord-1036869-qrrjh2zb authors: Karimi, Leila; Makvandi, Somayeh; Vahedian-Azimi, Amir; Sathyapalan, Thozhukat; Sahebkar, Amirhossein title: Effect of COVID-19 on Mortality of Pregnant and Postpartum Women: A Systematic Review and Meta-Analysis date: 2021-03-05 journal: J Pregnancy DOI: 10.1155/2021/8870129 sha: 17df0157f4b8465fb4578dabe963f21f6533b403 doc_id: 1036869 cord_uid: qrrjh2zb BACKGROUND: Based on what is known at this time, pregnant women are at an increased risk of severe illness from COVID-19 compared to nonpregnant women. Additionally, pregnant women with COVID-19 might have an increased risk of adverse pregnancy outcomes. To investigate the effects of coronavirus disease 2019 (COVID-19) on mortality of pregnant and postpartum women, we performed a systematic review of available published literature on pregnancies affected by COVID-19. METHODS: Web of Science, SCOPUS, and MEDLINE- databases were searched for original studies concerning the effect of COVID-19 on mortality of pregnant and postpartum women published by July 10, 2020. Meta-analyses of proportions were used to combine data and report pooled proportions. RESULTS: 117 studies with a total of 11758 pregnant women were included. The age ranged between 15 and 48 years. Most subjects were infected with SARS-CoV-2 in the third trimester. Disease severity was not reported in 1125 subjects. Maternal mortality was 1.3%. In 100% of fatal cases with adequate data, fever alone or with cough was one of the presenting symptoms. Also, dyspnea (58.3%) and myalgia (50%) were the most common symptoms. Sore throat (8.3%) and gastrointestinal symptoms (anorexia, nausea) (8.3%) were rare. The rate of comorbidities was 20% among COVID-19 deaths. The majority of COVID-19-infected women who died had cesarean section (58.3%), 25% had a vaginal delivery, and 16.7% of patients were not full term. CONCLUSION: COVID-19 infection in pregnant women was associated with higher rates (and pooled proportions) of cesarean section and mortality. Because new data are continuously being generated and published, the findings of this study can be complete and updated with new researches. The results of this study can guide and improve prenatal counseling of COVID-19-infected pregnant women. The coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global public health crisis [1, 2] . The impact of COVID-19 on specific populations, including pregnant women and their newborns, remains mostly unknown and unstudied. There is not sufficient information about the effect of this disease in pregnant women, and most available studies have evaluated the impact of the disease in the general population. Pregnant women are at a higher risk for acquiring viral respiratory infections and severe pneumonia due to physiological changes in their immune and cardiopulmonary systems [1] [2] [3] . The observed outcomes have been different from what was seen during the H1N1 pandemic and with influenza outbreaks, all of which resulted in increased mortality in women who were pregnant [4] . Studies in pregnant women during coronavirus outbreaks (SARS-CoV) and Middle East Respiratory Syndrome (MERS-CoV) show that pregnant women are susceptible to experiencing adverse events such as requiring hospitalization or intensive care unit (ICU) admission, endotracheal intubation, and renal failure [5] [6] [7] . Worldwide, there are more than 140 million births every year, and pregnant women are potentially at risk for adverse outcomes of novel coronavirus. Although maternal mortality has been reported in some studies, limited information is available about SARS-CoV-2 infection in critically ill pregnant women hospitalized for COVID-19 [8, 9] . Also, there is a multitude of case reports of infection with SARS-CoV-2 during pregnancy but their small sample size makes it difficult to properly find potential complications [10, 11] . The findings of a study on 8207 SARS-CoV-2-infected pregnant women showed an increased risk for ICU admission and mechanical ventilation compared with nonpregnant women; however, the risk for death was similar [12] . Also, the Centers for Disease Control and Prevention surveillance report from the United States noted that pregnant women were more likely to be admitted to the ICU and receive mechanical ventilation than nonpregnant women. However, after adjusting for age, presence of underlying medical conditions, and race/ethnicity, mortality rate was not increased [12] . Based on data from the early stage of pandemic, it is reassuring that there are low rates of maternal mortality with SARS-CoV-2 [13] . However, more studies are needed to learn more about maternal mortality. This study is aimed at performing a systematic review of available published literature on pregnancies affected by COVID-19 to evaluate the effect of COVID-19 on mortality of pregnant and postpartum women. This study is a systematic scoping review based on the methodological framework of Arksey and O'Malley [14] . Five stages of the framework they adopted for conducting a scoping study are as follows: (1) identifying the research question, (2) identifying relevant studies, (3) study selection, (4) charting the data, and (5) collating, summarizing, and reporting the results. The main questions of the study included the following. What is the mortality rate of COVID-19 in pregnant and postpartum women, and how many and what type of comorbidities were found in recovered and deceased patients? What were the disease symptoms and the mode of delivery in the maternal deaths? We searched scientific databases of Web of Science, SCOPUS, and MED-LINE through the interface, for original studies concerning the effect of COVID-19 on maternal death published until July 10, 2020. We designed a comprehensive optimal search strategy consisted of two components related to pregnancy and COVID-19. The complete search strategy is shown in Table 1 . Also, the Google Scholar engine was searched for potentially relevant articles. Eligible studies for inclusion in this systematic review were those that met all of the following criteria: (i) the analysis was performed in pregnant and postpartum women affected by COVID-19 (laboratory confirmed and/or clinically diagnosed) and (ii) the study was a full paper with original data and (iii) was written in English. Studies were excluded if they did not provide sufficient information about the patient outcome (survival or death and important related details). After removing the duplicates, the search output was screened as the first step. The titles and abstracts of the articles were screened by the two authors independently according to the eligibility criteria. Then, in the secondary screening, the full texts of the retrieved articles were reviewed by the same authors. Disagreements were resolved through discussion and consensus. A data collection form was designed by the authors to extract the data of the papers in an integrated way. Characteristics of the studies were extracted, including details of the first author's name, country, sample size, age, gestational age, comorbidities and complications in pregnancy, severity of COVID-19, ICU admission and ventilation Web of Science TOPIC: (pregnancy OR pregnan * OR gestation * OR conception) AND TOPIC: ("Novel coronavirus" OR "Novel coronavirus 2019" OR "2019 novel coronavirus" OR "2019 nCoV" OR "Wuhan coronavirus" OR "Wuhan pneumonia" OR covid-19 OR "2019-nCoV" OR "SARS-CoV-2" OR "coronavirus 2019" OR "2019-nCoV") SCOPUS (TITLE-ABS-KEY (pregnancy OR pregnan * OR gestation * OR conception) AND TITLE-ABS-KEY ("Novel coronavirus" OR "Novel coronavirus 2019" OR "2019 novel coronavirus" OR "2019 nCoV" OR "Wuhan coronavirus" OR "Wuhan pneumonia" OR covid-19 OR "2019-nCoV" OR "SARS-CoV-2" OR "coronavirus 2019" OR "2019-nCoV")) need, complications during treatment of COVID-19, and maternal mortality rate. In deceased patients, more information was extracted, including presenting symptoms, mode of delivery, duration of admission to death, and the result of the polymerase chain reaction (PCR) testing of the neonates. Data extraction was performed by two authors independently, and any disagreements were resolved through discussion and team consensus. 2.6. Statistical Analysis. All analyses were conducted by STATA16 (StataCorp, College Station, Texas, USA). The study statistician performed data extraction for primary outcomes. Random effect meta-analyses were applied using restricted maximum likelihood method [15] . The random effect model was used because there may be other unknown, unregistered/unpublished studies to which we could not have access. The between-study heterogeneity was evaluated using the Cochran Q test and Tau-squared, H-squared, and I-squared statistics. Significance results of the test and values higher than 75% for I-squared were considered as substantial heterogeneity while a value of H-squared = 1 indicates perfect homogeneity among the studies [16, 17] . The common effect sizes were calculated as the proportion and rate for binary and count outcomes, respectively, and their 95% confidence intervals (CIs). To assess the publication bias, the funnel plots were drawn. Additionally, Egger's [18] and Begg's [19] tests were conducted. A nonparametric "trim and fill" method of accounting for publication bias was performed and showed that there is no need for a modified effect size [20] . Finally, there were studies that have just one sample in some outcomes that conducted a sensitivity analysis by removing the studies with n = 1 sample. Considerations. The present study complies with all the recommended principles of research ethics. The official approval of the Research Ethics Committee was not obtained for this study because it was a review of the findings of other previously published papers that were available to the public. To comply with the ethical principles, the authors did their best to avoid plagiarism and refused to manipulate the data for personal interests. Respect for the rights of other authors was provided by citing them in the text of the study when information belonging to them was expressed. Journal of Pregnancy Figure 1 shows the PRISMA flow chart for study selection. The search strategy retrieved 1348 records and 4 additional records identified through Google Scholar search. After removing 632 duplicates, 720 titles and abstracts were screened. In the second screening, 167 full texts were evaluated and a total of 117 studies were included in the systematic review. 3.2. General Characteristics. The characteristics of the included studies are shown in Table 2 . A total of 11758 pregnant women entered the review study ranging from 1 to 8207 per study. The age range of patients was between 15 and 48 years. Most subjects were infected with SARS-CoV-2 in the third trimester. Disease severity was not reported in 1125 samples. In the remaining cases, the highest frequency was related to asymptomatic COVID-19 (n = 5466, 51.4%). In terms of the country of origin, the highest frequencies were in China with 34 articles [8, 12, , the United States with 33 articles [5, 8, 12, , and Italy with 8 articles [52] [53] [54] [55] [56] [57] [58] [59] . 65 studies including 10183 patients were undertaken in the high-income countries [5, 8, 12, and 52 studies (n = 1575) in middle-income countries [21, . The data on 136 cases of maternal death due to COVID-19 is presented in Table 3 . The highest mortality rate was reported in the study of Takemoto et al. in Brazil using the Brazilian Ministry of Health's ARDS Surveillance System. In this study, the authors found 124 deaths in COVID-19infected pregnant or postpartum women (12.7%) [131] . Postpartum Women Who Died of COVID-19. In all of the fatal cases with adequate data, fever alone or with cough was one of the presenting symptoms. After them, dyspnea (58.3%) and myalgia (50%) were the most common symptoms, respectively. Sore throat (8.3%) and gastrointestinal symptoms (anorexia, nausea) (8.3%) were rare. Who Died of COVID-19. The comorbidity rate in women who died from COVID-19 was 20% (Table 3 ). In total, 41.7% of the deceased patients were 35 years or older (advanced maternal age), 31.1% had diabetes, 21.9% were obese, 14.1% had cardiovascular disease (essential hypertension, gestational hypertension, preeclampsia, HELLP syn-drome, and heart problems), and 9.1% had a history of asthma. Died of COVID-19. The effect size in five studies for obesity Figure 2 shows the forest plot of individual effect sizes within each study. Assessment for bias by Egger's and Begg's tests showed no significant small-study effects (all P > 0:05). Further visual inspection of the funnel plot suggested a slight degree of publication bias (Figure 3 ). (1) Obesity in All Pregnant and Postpartum Women Affected by COVID-19. The proportion from 33 studies was 0.69 (95% CI: 0.56 to 0.82, P value < 0.001) based on a random effect model, with significant heterogeneity between studies (τ 2 = 0:14, I 2 = 100:0%, H 2 = 1:28e + 11, Q ðdf =32Þ = 9:68e + 11, P Q < 0:001). Figure 4 shows the forest plot of individual effect sizes within each study. Assessment for bias by Egger's and Begg's tests showed no significant small-study effects (P = 0:308 > 0:05 and P = 0:054 > 0:05, respectively). Further visual inspection of the funnel plot suggests a slight degree of publication bias ( Figure 5 ). (2) Sensitivity Analysis after Deleting the Studies with n=1. Removing these studies resulted in an effect size Pr = 0:49 (95% CI: 0.33 to 0.66, P value < 0.001), with a significant heterogeneity (τ 2 = 0:12, I 2 = 100:0%, H 2 = 8:72e + 10, Q ðdf =17Þ = 1:07e + 07, P Q < 0:001). Figure 6 shows the forest plot of individual effect sizes within each study. . Therefore, the test showed a significant difference between the subgroups (Q ðdf =1Þ = 13:58, P Q < 0:001). Additionally, the heterogeneity did not reduce in all subgroups (I 2 = 93:65% and I 2 = 100% in the recovered and deceased subgroups, respectively). Figure 8 shows the forest plot of individual effect sizes within each study. Assessment for bias by Egger's and Begg's tests showed no significant small-study effects (P = 0:969 > 0:05 and P = 0:339 > 0:05, respectively). Further visual inspection of the funnel plot suggested a slight degree of publication bias (Figure 9 ). (2) Sensitivity Analysis after Deleting the Studies with n=1. Removing these studies resulted in an effect size Pr = 0:18 (95% CI: 0.11 to 0.25, P value < 0.001), with a significant Test of i = j : Q (32) = 9.68e + 11, P = 0.00 Test of = 0: z = 10.48, P = 0.00 Journal of Pregnancy heterogeneity (τ 2 = 0:04, I 2 = 100:0%, H 2 = 1:76 + 5, Q ðdf =27Þ = 5:95e + 07, P Q < 0:001). Figure 10 shows the forest plot of individual effect sizes within each study. Pregnant and Postpartum Women. The forest plot of the individual effect size of predetermined subgroup analysis by dead/recovered is presented in Figure 11 . The results indicate lower proportion of outcome in the recovered subgroup (Pr = 0:18, 95%CI = 0:10 to 0.25), than in the dead subgroup (Pr = 0:18, 95%CI = 0:11 to 0.25), so that the test showed a nonsignificant difference between the subgroups (Q ðdf =1Þ = 0:37, P Q = 0:54 > 0:05). Additionally, the heterogeneity did not reduce in all subgroups (I 2 = 100:0% and I 2 = 99:17% in the recovered and dead subgroups, respectively). (1) Cardiovascular Diseases in All Pregnant and Postpartum Women Affected by COVID-19. The proportion from 40 studies was 0.36 (95% CI: 0.24 to 0.48, P value < 0.001) based on a random effect model, with significant heterogeneity between studies (τ 2 = 0:15, I 2 = 100:0%, H 2 = 3:52e + 10, Q ðdf =39Þ = 3:42e + 8, P Q < 0:001). Figure 12 shows the forest plot of individual effect sizes within each study. Assessment for bias by Egger's and Begg's tests showed no significant small-study effects (P = 0:942 > 0:05 and P = 0:129 > 0:05, respectively). Further visual inspection of the funnel plot suggested a slight degree of publication bias ( Figure 13 ). (2) Sensitivity Analysis after Deleting the Studies with n=1. Removing these studies resulted in an effect size Pr = 0:14 (95% CI: 0.10 to 0.18, P value < 0.001), with a significant heterogeneity (τ 2 = 0:01, I 2 = 100:0%, H 2 = 2:15e + 4, Q ðdf =29Þ = 2:57e + 04, P Q < 0:001). Figure 14 shows the forest plot of individual effect sizes within each study. Test of i = j : Q (17) = 1.07e + 7, P = 0.00 Test of = 0: z = 5.91, P = 0.00 19 Journal of Pregnancy the heterogeneity did not reduce in all subgroup especially (I 2 = 100:0% and I 2 = noncomputable in the recovered and dead subgroups, respectively). Who Died of COVID-19. The mode of delivery in deceased cases with sufficient data (n = 12) was as follows: 58.3% had cesarean section, 25% had vaginal delivery, and 16.7% were not full term. Meta-analysis for mode of delivery in the fatal cases showed that the proportion from 6 studies was 0.00 (95% CI: -0.03 to 0.04, P value = 0.96) based on a random effect model, with nonsignificant heterogeneity between studies (τ 2 = 0:00, I 2 = 0:03%, H 2 = 1, Q ðdf =5Þ = 2:99, P Q = 0:70). Figure 16 shows the forest plot of individual effect sizes within each study. Assessment for bias by Egger's and Begg's tests showed no significant small-study effects (P = 0:084 > 0:05 and P = 0:181 > 0:05, respectively). Further visual inspection of the funnel plot suggested a slight degree of publication bias ( Figure 17 ). 3.3.9. Other Findings. Duration from admission to death was between 2 and 22 days [85, 124] . The most common complication during treatment of COVID-19 in pregnant and postpartum women was acute respiratory distress syndrome (ARDS). In fatal cases, PCR testing of the neonate was not indicated in 41.6% of cases (stillbirth, undelivered). In 41.6%, it was negative, and in 16.7% of the cases, the result of the initial test was negative and the second test was positive [124, 134] . In this study, we systematically investigated 117 published reports involving 11758 pregnant women from the high-and middle-income countries assessing the effect of COVID-19 on the risk of mortality. In this systematic review, the mortality rate of COVID-19 in pregnant and postpartum women was 1.30% and the rate of severe pneumonia was reported from 0 to 14%. The majority of the patients were admitted to the ICU, and the maternal death was consistent with reported outcomes from other severe viral lower respiratory tract infections [5, [135] [136] [137] [138] [139] [140] . Unlike the current study, in some studies, the mortality rate of COVID-19-infected pregnant women was not higher than nonpregnant women of reproductive age [13, 58, 141] . The absence of deaths was explained by the younger age pregnant women who were infected because it has been shown that the Figure 9 : Funnel plot of log relative risks vs. the standard error for diabetes. 21 Journal of Pregnancy mortality rate in COVID-19 patients is high in older individuals and those patients with at least one comorbidity [127] . Also, the number of cases in these studies was relatively small and all women were in their third trimester of pregnancy and most of them gave birth earlier than seven days after diagnosis of the disease. Hence, this clinical manifestation-todelivery time may be too short to affect pregnancies [142] . Additionally, this discrepancy may be due to the data available at the time of publication in our study. The pregnancyrelated immunological changes may be one of the causes of maternal vulnerability to COVID-19, but this did not significantly affect the response against SARS-CoV-2 [142] . In addition, maternal mortality rates were lower in highincome compared with low-income countries. In this systematic review, most of the studies were from China. It is possible that our study reported a higher mortality rate than other studies because our sample size was larger. Similar to this finding, it was shown that the incidence of maternal mortality rate in middle-income countries seems at least six times higher than that in high-income countries [142] . These findings indicate the weaknesses of maternity services in lowincome countries. In addition, major barriers for a more equitable delivery of critical care in low-income countries may be an important factor, such that in Brazil-a middleincome country-only 72% of COVID-19-infected pregnant or postpartum women with COVID-19 were admitted to the ICU and 15% of them did not receive ventilation support [131] . In Mexico, only two out of seven deaths had been admitted to the ICU and received invasive respiratory assistance [143] . Viral pneumonia is one of the leading causes of pregnancy deaths worldwide [12] . The symptoms of pneumonia Figure 10 : Forest plot of individual effect size for obesity after removing some studies. Journal of Pregnancy in pregnant women are not different from others [144] . Maternal deaths due to cardiopulmonary complications, sometimes with multiorgan failure, have been reported in the previous literatures [9, 31, 102, 145] . In one study, pregnant women with SARS-CoV-2 infection in their second or third trimester of pregnancy died due to cardiopulmonary complications [9] . In all of the fatal cases, fever alone or with cough, dyspnea, and myalgia were the most common symptoms, respectively. Sore throat and gastrointestinal symptoms were rare. In accordance with this finding in another systematic review, the most common symptoms at presentation were fever, cough, dyspnea/shortness of breath, fatigue, and myalgia [146] . Data from nonpregnant adults have described the Figure 11 : Forest plot of individual effect size for obesity by subgroups. 23 Journal of Pregnancy most common presenting symptoms of COVID-19 as fever, cough, and dyspnea [147, 148] . In contrast with our review, in some other systematic reviews, the symptoms were significantly different with fever and cough occurring more than myalgia as well as dyspnea and fatigue occurring only in approximately one-sixth of symptomatic pregnant women [3, [149] [150] [151] [152] [153] . Another finding in this study was the high prevalence of maternal comorbidities. The comorbidity rate in deceased women was 20%, and most of the pregnant women show biochemical evidence of inflammation, mainly lymphopenia. However, in one study, nearly half of all patients (46%) had no baseline comorbidities [31] . In another study, approximately one out of every three women with SARS-CoV-2 infection had a comorbid condition, but no maternal deaths secondary to COVID-19 were reported [13] . High comorbidity and lack of maternal mortality may be due to the younger Barile Test of i = j : Q (39) = 3.41e + 08, P = 0.00 Test of = 0: z = 5.84, P = 0.00 [148] which makes management of comorbidities challenging. Also, these comorbidities per se could cause maternal deaths. Advanced maternal age (age > 35) was the most prevalent comorbidity; other comorbidities included diabetes, obesity, cardiovascular disease (essential hypertension, gestational hypertension, preeclampsia, HELLP syndrome, and heart problems), and history of asthma, respectively. These comor-bidities suggest that maternal morbidity is not different from nonpregnant women of reproductive age. In one study, obesity and pulmonary conditions such as asthma and obstructive sleep apnea (OSA) were the most common comorbidities. Also, maternal ICU admission was one of the other outcomes. Also, pregnant and postpartum women with COVID-19 admitted to the ICUs are at risk for maternal death, which may occur even in the absence of substantial baseline comorbidities [31, 148] . Another comorbidity was antiviral drug use [146, 148] ; while these two causes were Test of i = j : Q (29) = 25677.64, P = 0.00 Test of = 0: z = 6.80, P = 0.00 Figure 14 : Forest plot of individual effect size for obesity after removing some studies. 25 Journal of Pregnancy not found in our study, the comorbidities could indirectly lead to patients' ICU admission and administration of antiviral drugs. In contrast to our study, another study showed none of the pregnant patients had preexisting comorbidities, such as hypertension, cardiovascular disease, and asthma [9, 146] . Based on the results, the majority of deliveries in pregnant women with SARS COVID-19 were cesarean section. Similar to this result, COVID-19 infection was associated with a relatively higher cesarean delivery in other studies [10, 31, 146] . Also, in another systematic review, the rate of cesarean delivery was higher than in our study because more than 90% of cesarean sections were from China (306/332). Some articles from China have shown SARS-CoV-2 infection as an indication for cesarean delivery [154] [155] [156] , thereby justifying such a difference in the rate of cesarean section. In Test of i = j : Q (29) = 25677.64, P = 0.00 Heterogeneity: 2 = 0.00, I 2 = .%, H 2 = . Test of i = j : Q (0) = 0.00 P = . [157] . In the study by Khalil et al., the rate of cesarean section in mothers with COVID-19 was less than in our study. This difference can be explained by the fact that in the study by Khalil et al., the rate of comorbidity was higher than our study (32.5% vs. 20%), and this issue could be the reason for the cesarean section rate reduction. There are no data available for the first and early second trimester of pregnancy infections. Other limitation is the retrospective design (especially reports and case series) of the study. Also, we have only included studies which are reported in the English language. The strengths of this study are large number of studies, relatively high sample size, and the inclusion of studies from different countries. COVID-19 infection was associated with higher rates (and pooled proportions) of cesarean section in pregnant women and their mortality. Based on the results of this study, COVID-19 cannot be considered as an indication for caesarian delivery. Therefore, the timing and mode of delivery should be individualized based on obstetrical indication and maternal situation. The findings of this study can be a guide to prenatal enhanced counseling for pregnant women with COVID-19. Data are available from the first and corresponding authors upon a reasonable request. The authors report no conflict of interest. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China How does COVID-19 affect pregnancy and postpartum care? Pregnancy affected by SARS-CoV-2 infection: a flash report from Michigan Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome A novel coronavirus associated with severe acute respiratory syndrome A postpartum death due to coronavirus disease 2019 (COVID-19) in the United States Maternal death due to COVID-19 Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis Labor and delivery guidance for COVID-19 Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by severe acute respiratory syndrome coronavirus 2 (SARS-Co-V-2) Infection Scoping studies: towards a methodological framework The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate health care interventions: explanation and elaboration A likelihood approach to meta-analysis with random effects Quantifying heterogeneity in a meta-analysis Bias in meta-analysis detected by a simple, graphical test Operating characteristics of a rank correlation test for publication bias A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints Postpartum exacerbation of antenatal COVID-19 pneumonia in 3 women The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: a case report Acute respiratory distress syndrome in a preterm pregnant patient with coronavirus disease 2019 (COVID-19) Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals Coronavirus disease 2019 in pregnancy: early lessons Successful treatment of preterm labor in association with acute COVID-19 infection Universal SARS-Cov-2 screening in women admitted for delivery in a large managed care organization COVID-19 in pregnant women: case series from one large New York City obstetrical practice Covid-19 and hellp: overlapping clinical pictures in two gravid patients Prevalence and severity of coronavirus disease 2019 (COVID-19) illness in symptomatic pregnant and postpartum women stratified by Hispanic ethnicity Clinical implications of SARS-CoV-2 infection in the viable preterm period Care of critically ill pregnant patients with coronavirus disease 2019: a case series Severe COVID-19 infection in pregnancy requiring intubation without preterm delivery: a case report An uncomplicated delivery in a patient with Covid-19 in the United States Two cases of coronavirus 2019-related cardiomyopathy in pregnancy False-negative testing for severe acute respiratory syndrome coronavirus 2: consideration in obstetrical care Characteristics and outcomes of 241 births to women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at five New York City medical centers Clinical characteristics of 46 pregnant women with a SARS-CoV-2 infection in Washington state The relationship between status at presentation and outcomes among pregnant women with COVID-19 Mechanical ventilation in pregnancy due to COVID-19: a cohort of three cases Novel coronavirus-related acute respiratory distress syndrome in a patient with twin pregnancy: a case report A mechanistic analysis placental intravascular thrombus formation in COVID-19 patients Tocilizumab and remdesivir in a pregnant patient with coronavirus disease 2019 (COVID-19) Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study COVID-19 infection presenting as pancreatitis in a pregnant woman: a case report Detection of COVID-19 in a vulvar lesion Severe acute respiratory distress syndrome in coronavirus disease 2019-infected pregnancy: obstetric and intensive care considerations Acute respiratory decompensation requiring intubation in pregnant women with SARS-CoV-2 (COVID-19) Heart failure with preserved ejection fraction in a postpartum patient with superimposed preeclampsia and COVID-19 Induction of labor in an intubated patient with coronavirus disease 2019 (COVID-19) Prone ventilation in a 27 week pregnant woman with COVID-19 severe ards Clinical role of lung ultrasound for diagnosis and monitoring of COVID-19 pneumonia in pregnant women Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 pregnant patients: is it time to think about it? Delivery in asymptomatic Italian woman with SARS-CoV-2 infection Haemophilus parainfluenzae endocarditis with multiple cerebral emboli in a pregnant woman with coronavirus Report of positive placental swabs for sars-cov-2 in an asymptomatic pregnant woman with covid-19 Pulmonary embolism in a young pregnant woman with COVID-19 Clinical findings and disease severity in hospitalized pregnant women with coronavirus disease 2019 (COVID-19) First COVID-19 maternal mortality in the UK associated with thrombotic complications Second-trimester miscarriage in a pregnant woman with SARS-CoV-2 infection Covid-19 in pregnant women: general data from a French National Survey Public Health Agency of Sweden's brief report: pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden SARS-CoV-2 infection in very preterm pregnancy: experiences from two cases Covid-19 during pregnancy: a case series from an universally tested population from the north of Portugal COVID-19 infection during the third trimester of pregnancy: current clinical dilemmas COVID-19 in pregnancy with comorbidities: more liberal testing strategy is needed Pregnancy and perinatal outcome of a woman with COVID-19 infection Re: Novel coronavirus COVID-19 in late pregnancy: outcomes of first nine cases in an inner city London hospital No evidence of vertical transmission of SARS-CoV-2 after induction of labour in an immune-suppressed SARS-CoV-2-positive patient A snapshot of the Covid-19 pandemic among pregnant women in France Placental abruption in a twin pregnancy at 32 weeks' gestation complicated by COVID-19, without vertical transmission to the babies COVID-19 vaginal delivery -a case report Cesarean section in a pregnant woman with COVID-19: first case in Portugal Association between mode of delivery among pregnant women with COVID-19 and maternal and neonatal outcomes in Pre-eclampsialike syndrome induced by severe COVID-19: a prospective observational study Immune thrombocytopenia flare with mild COVID-19 infection in pregnancy: a case report Clinical course of coronavirus disease-2019 in pregnancy Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: a single-centre cohort study from Spain COVID-19 in pregnancy was associated with maternal morbidity and preterm birth Prone positioning and high-flow oxygen improved respiratory function in a 25-week pregnant woman with COVID-19 Retrospective description of pregnant women infected with severe acute respiratory syndrome coronavirus 2, France Probable congenital sars-cov-2 infection in a neonate born to a woman with active sars-cov-2 infection COVID-19 pneumonia in an Iraqi pregnant woman with preterm delivery Multidisciplinary team management and cesarean delivery for a Jordanian woman infected with SARS-COV-2: a case report Severe COVID-19 during pregnancy and possible vertical transmission Successful anesthetic management in cesarean section for pregnant woman with COVID-19 Virolactia in an asymptomatic mother with COVID-19 Clinical analysis of ten pregnant women with COVID-19 in Wuhan, China: a retrospective study Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Clinical characteristics of pregnant women with Covid-19 in Wuhan, China Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing cesarean delivery: a case series of 17 patients Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia Infants born to mothers with a new coronavirus (COVID-19) Anaesthetic management of a COVID-19 parturient for caesarean section -case report and lessons learnt Anesthesia and protection in an emergency cesarean section for pregnant woman infected with a novel coronavirus: case report and literature review Perinatal transmission of COVID-19 associated SARS-CoV-2: should we worry? The first pregnant woman with COVID-19 in Venezuela: pre-symptomatic transmission Maternal death due to COVID-19 disease Unfavorable outcomes in pregnant patients with COVID-19 outside Wuhan, China Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19 Mortality of a pregnant patient diagnosed with COVID-19: a case report with clinical, radiological, and histopathological findings Impact of COVID-19 infection on pregnancy outcomes and the risk of maternalto-neonatal intrapartum transmission of COVID-19 during natural birth Can SARS-CoV-2-infected women breastfeed after viral clearance? Maternal and neonatal outcomes of pregnant women with Coronavirus Disease 2019 (COVID-19) pneumonia: a case-control study COVID-19 in pregnant women: a systematic review and meta-analysis Chest CT findings in a pregnant patient with 2019 novel coronavirus disease Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis Clinical and CT imaging features of the COVID-19 pneumonia: focus on pregnant women and children Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission Prolonged viral persistence in COVID-19 second trimester pregnant patient Unlikely SARS-CoV-2 vertical transmission from mother to child: a case report Coronavirus disease 2019 in pregnancy Twin pregnant woman with COVID-19: a case report Acute kidney injury in pregnant women following SARS-CoV-2 infection: a case report from Iran The tragedy of COVID-19 in Brazil: 124 maternal deaths and counting Possible formation of pulmonary microthrombi in the early puerperium of pregnant women critically ill with COVID-19: two case reports A case of 2019 Novel coronavirus in a pregnant woman with preterm delivery Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China Clinical manifestation and laboratory characteristics of SARS-CoV-2 infection in pregnant women Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding Emergency caesarean delivery in a patient with confirmed COVID-19 under spinal anaesthesia Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID--19 Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates Coronavirus disease 2019 (COVID-19) in pregnant women: a report based on 116 cases Effects of SARS-CoV-2 infection on pregnant women and their infants: a retrospective study in Wuhan, China Lung ultrasound can influence the clinical treatment of pregnant women with COVID-19 Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study Preterm delivery, maternal death, and vertical transmission in a pregnant woman with COVID-19 infection A pregnant woman with COVID-19 in Central America Update on clinical outcomes of women with COVID-19 during pregnancy Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China Effects of influenza on pregnant women and infants Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome Normal pregnancy Hormonal regulation of physiology, innate immunity and antibody response to H1N1 influenza virus infection during pregnancy 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature Coronavirus disease 2019 (COVID-19): pregnancy issues Analysis of maternal coronavirus infections and neonates born to mothers with 2019-nCoV; a systematic review Risk factors for adverse outcomes among pregnant and postpartum women with acute respiratory distress syndrome due to COVID-19 in Brazil Maternal mortality from COVID-19 in Mexico Risks of novel coronavirus disease (COVID-19) in pregnancy; a narrative review Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review Clinical characteristics of coronavirus disease 2019 in China SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis of clinical features and pregnancy outcomes Clinical features of patients infected with the 2019 novel coronavirus (COVID-19 Delivery in pregnant women infected with SARS-CoV-2: A fast review A patient with SARS-CoV-2 infection during pregnancy in Qingdao, China Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn Antibodies in infants born to mothers with COVID-19 pneumonia Methodological quality and synthesis of case series and case reports Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia Community transmission of severe acute respiratory syndrome coronavirus 2 Mode of delivery and clinical findings in COVID-19 infected pregnant women in Northern Italy Thanks are due for the financial support, guidance, and advice from the "Clinical Research Development Unit of Baqiyatallah Hospital."